U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C24H32N2O3
Molecular Weight 396.5225
Optical Activity UNSPECIFIED
Defined Stereocenters 3 / 3
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ENADOLINE

SMILES

CN([C@H]1CC[C@@]2(CCCO2)C[C@@H]1N3CCCC3)C(=O)CC4=CC=CC5=C4C=CO5

InChI

InChIKey=JMBYBVLCYODBJQ-HFMPRLQTSA-N
InChI=1S/C24H32N2O3/c1-25(23(27)16-18-6-4-7-22-19(18)9-15-28-22)20-8-11-24(10-5-14-29-24)17-21(20)26-12-2-3-13-26/h4,6-7,9,15,20-21H,2-3,5,8,10-14,16-17H2,1H3/t20-,21-,24-/m0/s1

HIDE SMILES / InChI

Molecular Formula C24H32N2O3
Molecular Weight 396.5225
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 3 / 3
E/Z Centers 0
Optical Activity UNSPECIFIED

Enadoline (CI-977) is a potent and selective agonist at the kappa-opioid receptor. Enadoline is a potent antinociceptive agent. Clinical use of enadoline was associated with dose-limiting neuropsychiatric adverse events. Enadoline may yet find some application against ischaemic stroke and severe head injury, presumably in comatose patients.

Approval Year

PubMed

PubMed

TitleDatePubMed
Design and synthesis of novel dimeric morphinan ligands for kappa and micro opioid receptors.
2003-11-20
Analysis of [3H]bremazocine binding in single and combinatorial opioid receptor knockout mice.
2001-03-02
Radioligand-dependent discrepancy in agonist affinities enhanced by mutations in the kappa-opioid receptor.
1996-10
CI-977, a novel and selective agonist for the kappa-opioid receptor.
1990-09

Sample Use Guides

20, 40, 80, and 160 microg/70 kg. The highest dose (160 microg/70 kg) was not tolerated and led to psychotomimetic effects.
Route of Administration: Intramuscular
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:22:03 GMT 2025
Edited
by admin
on Mon Mar 31 18:22:03 GMT 2025
Record UNII
KJL283326C
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
4-BENZOFURANACETAMIDE, N-METHYL-N-(7-(1-PYRROLIDINYL)-1-OXASPIRO(4.5)DEC-8-YL)-, (5R-(5.ALPHA.,7.ALPHA.,8.BETA.))-
Preferred Name English
ENADOLINE
HSDB   INN  
INN  
Official Name English
ENADOLINE [HSDB]
Common Name English
N-METHYL-N-((5R,7S,8S)-7-(1-PYRROLIDINYL)-1-OXASPIRO(4.5)DEC-8-YL)-4-BENZOFURANACETAMIDE
Systematic Name English
enadoline [INN]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C67413
Created by admin on Mon Mar 31 18:22:03 GMT 2025 , Edited by admin on Mon Mar 31 18:22:03 GMT 2025
Code System Code Type Description
CAS
124378-77-4
Created by admin on Mon Mar 31 18:22:03 GMT 2025 , Edited by admin on Mon Mar 31 18:22:03 GMT 2025
PRIMARY
FDA UNII
KJL283326C
Created by admin on Mon Mar 31 18:22:03 GMT 2025 , Edited by admin on Mon Mar 31 18:22:03 GMT 2025
PRIMARY
WIKIPEDIA
Enadoline
Created by admin on Mon Mar 31 18:22:03 GMT 2025 , Edited by admin on Mon Mar 31 18:22:03 GMT 2025
PRIMARY
HSDB
7677
Created by admin on Mon Mar 31 18:22:03 GMT 2025 , Edited by admin on Mon Mar 31 18:22:03 GMT 2025
PRIMARY
EVMPD
SUB06513MIG
Created by admin on Mon Mar 31 18:22:03 GMT 2025 , Edited by admin on Mon Mar 31 18:22:03 GMT 2025
PRIMARY
ChEMBL
CHEMBL318859
Created by admin on Mon Mar 31 18:22:03 GMT 2025 , Edited by admin on Mon Mar 31 18:22:03 GMT 2025
PRIMARY
MESH
C067110
Created by admin on Mon Mar 31 18:22:03 GMT 2025 , Edited by admin on Mon Mar 31 18:22:03 GMT 2025
PRIMARY
NCI_THESAURUS
C80576
Created by admin on Mon Mar 31 18:22:03 GMT 2025 , Edited by admin on Mon Mar 31 18:22:03 GMT 2025
PRIMARY
SMS_ID
100000080202
Created by admin on Mon Mar 31 18:22:03 GMT 2025 , Edited by admin on Mon Mar 31 18:22:03 GMT 2025
PRIMARY
INN
7027
Created by admin on Mon Mar 31 18:22:03 GMT 2025 , Edited by admin on Mon Mar 31 18:22:03 GMT 2025
PRIMARY
EPA CompTox
DTXSID4047258
Created by admin on Mon Mar 31 18:22:03 GMT 2025 , Edited by admin on Mon Mar 31 18:22:03 GMT 2025
PRIMARY
PUBCHEM
60768
Created by admin on Mon Mar 31 18:22:03 GMT 2025 , Edited by admin on Mon Mar 31 18:22:03 GMT 2025
PRIMARY
Related Record Type Details
TARGET -> AGONIST
SALT/SOLVATE -> PARENT
Related Record Type Details
ACTIVE MOIETY